Lyell Immunopharma Inc (LYEL)

04:42 AM

China Universal Asset Management Co. Ltd. Has $26,000 Position in Lyell Immunopharma, Inc. $LYEL - Defense World

04:42 AM

Dec 14, 2025

HSG Holding Ltd Cuts Position in Lyell Immunopharma, Inc. $LYEL - MarketBeat

Dec 14, 2025

Dec 13, 2025

1,820,634 Shares in Lyell Immunopharma, Inc. $LYEL Bought by ARCH Venture Management LLC - MarketBeat

Dec 13, 2025

Dec 11, 2025

Lyell ImmunoPharma announces new data from trial of rondecabtagene autoleucel - MSN

Dec 11, 2025

Dec 11, 2025

Lyell Immunopharma (NASDAQ:LYEL) Sets New 12-Month HighShould You Buy? - MarketBeat

Dec 11, 2025

Dec 10, 2025

Aug Technicals: Why Lyell Immunopharma Inc stock could outperform in 2025Weekly Gains Summary & Smart Swing Trading Alerts - moha.gov.vn

Dec 10, 2025

Dec 10, 2025

Lyell Immunopharma (NASDAQ:LYEL) Trading Up 11.4%Should You Buy? - MarketBeat

Dec 10, 2025

Dec 10, 2025

What analysts say about Lyell Immunopharma Inc stockConsumer Goods Stocks & High Return Capital Growth - earlytimes.in

Dec 10, 2025

Dec 10, 2025

100,000 Shares in Lyell Immunopharma, Inc. $LYEL Bought by RBF Capital LLC - MarketBeat

Dec 10, 2025

Dec 09, 2025

Lyell Immunopharma Shares Rise After HC Wainwright Upgrade - marketscreener.com

Dec 09, 2025

Dec 09, 2025

H.C. Wainwright upgrades Lyell to 'buy' on cell therapy progression - TradingView — Track All Markets

Dec 09, 2025

Dec 09, 2025

This Eaton Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga

Dec 09, 2025

Dec 09, 2025

Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors - GlobeNewswire Inc.

Dec 09, 2025

Dec 09, 2025

LYEL Analyst Rating Upgrade: HC Wainwright & Co. Sets New Price Target | LYEL Stock News - GuruFocus

Dec 09, 2025

Dec 09, 2025

HC Wainwright & Co. Upgrades Lyell Immunopharma (LYEL) - Nasdaq

Dec 09, 2025

Dec 08, 2025

Lyell Immunopharma climbs after reporting strong CAR T-cell therapy results - MSN

Dec 08, 2025

Dec 08, 2025

Lyell Immunopharma stock rises on strong cancer therapy trial data By Investing.com - Investing.com Nigeria

Dec 08, 2025

Dec 08, 2025

Lyell Immunopharma stock rises on strong cancer therapy trial data - Investing.com

Dec 08, 2025

Dec 08, 2025

Lyell Immunopharma Presents Promising CAR T-Cell Data - TipRanks

Dec 08, 2025

Dec 07, 2025

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition - GlobeNewswire

Dec 07, 2025

Dec 07, 2025

Lyell Immunopharma (Nasdaq: LYEL) posts 76% complete responses with ronde-cel in LBCL - Stock Titan

Dec 07, 2025

Dec 07, 2025

Lyell Immunopharma (NASDAQ:LYEL) Sets New 12-Month High – Here’s What Happened - Defense World

Dec 07, 2025

Dec 05, 2025

Lyell Immunopharma Modernizes Bylaws for Shareholder Engagement - TipRanks

Dec 05, 2025

Dec 05, 2025

Lyell Immunopharma (NASDAQ:LYEL) Stock Price Up 11.6%Should You Buy? - MarketBeat

Dec 05, 2025

Dec 05, 2025

Will Lyell Immunopharma Inc. stock sustain high P E ratiosTrade Signal Summary & Growth Oriented Trading Recommendations - Newser

Dec 05, 2025

Dec 04, 2025

Decheng Capital LLC Sells 11,313,875 Shares of Lyell Immunopharma, Inc. $LYEL - MarketBeat

Dec 04, 2025

Dec 02, 2025

ASH 2025 Roundup: Companies With Key Data Presentations - RTTNews

Dec 02, 2025

Nov 29, 2025

What drives Lyell Immunopharma Inc stock priceHigh Beta Stocks & Free High Yield Growth Strategies - earlytimes.in

Nov 29, 2025

Nov 27, 2025

Lyell Immunopharma (NASDAQ:LYEL) Hits New 52-Week HighHere's What Happened - MarketBeat

Nov 27, 2025

Nov 26, 2025

Lyell Immunopharma Secures Global Rights for LYL273 - MSN

Nov 26, 2025

Nov 26, 2025

Published on: 2025-11-26 22:33:12 - BỘ NỘI VỤ

Nov 26, 2025

Nov 26, 2025

Foresite Capital Management V LLC Trims Stock Position in Lyell Immunopharma, Inc. $LYEL - MarketBeat

Nov 26, 2025

Nov 24, 2025

Lyell Immunopharma (LYEL) Sees Price Target Doubling by HC Wainw - GuruFocus

Nov 24, 2025

Nov 23, 2025

ETFs Investing in Lyell Immunopharma, Inc. Stocks - TradingView

Nov 23, 2025

Nov 22, 2025

Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) one-year returns climbed after last week's 13% gain, institutional investors must be happy - simplywall.st

Nov 22, 2025

Nov 21, 2025

Is Lyell Immunopharma Inc. stock trading at a premium valuationJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com

Nov 21, 2025

Nov 21, 2025

How Lyell Immunopharma Inc. stock performs in rate cut cyclesJuly 2025 Momentum & Technical Pattern Based Signals - newser.com

Nov 21, 2025

Nov 21, 2025

Will Lyell Immunopharma Inc. stock pay special dividendsJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com

Nov 21, 2025

Nov 19, 2025

Real time social sentiment graph for Lyell Immunopharma Inc.Weekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Lyell Immunopharma Inc. benefit from macro trendsQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com

Nov 19, 2025

Nov 19, 2025

How Lyell Immunopharma Inc. stock performs in weak economyTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Is it too late to sell Lyell Immunopharma Inc.Weekly Investment Recap & Daily Stock Momentum Reports - newser.com

Nov 18, 2025

Nov 18, 2025

Is Lyell Immunopharma Inc. stock attractive for retirement portfoliosLayoff News & Safe Entry Point Alerts - newser.com

Nov 18, 2025